AI generated image of a man with a question mark illumined on his forehead with strands of DNA floating behind him.
Featured Post

IU Center for Bioethics tackles complex issues of humanity surrounding emergent medical technologies

Researchers with the IU Center for Bioethics tackle ethical questions in medicine with topics including weight loss drugs, AI, organ transplantation, genetic testing, biobanks, end-of-life care, reproductive medicine, health equity and research integrity.

Laura Gates  | Aug 27, 2025
Clayton Hicks

Evaluating Patient Decisions: Dr. Schwartz's View

Peter Schwartz, MD, PhD, director of the IU Center for Bioethics and Professor of Medicine and Bioethics at IU School of Medicine, presented at Bioethics

Clayton Hicks
Clayton Hicks

Insulin Price Controls, Who Falls Through the Gaps?

Insulin price controls have recently emerged to contain the out of pocket cost of insulin, but not everyone is protected. This blog discusses the current

Clayton Hicks
Peter Schwartz, MD, PhD

AI and Bioethics: Professor Hartsock's View

On October 24, 2024, Jane Hartsock, JD, MA, presented 'The Sky is Falling! The Ethical Implications of Artificial Intelligence and Large Language Models" as part

Peter Schwartz, MD, PhD
Morgan Rich

Who Deserves Ozempic? The Ethical Challenges of Weight-Loss Use

As the new ‘miracle drug’ for weight loss, Ozempic is one of the most popular new drugs in America, and there isn’t enough Ozempic for

Morgan Rich
Sam Vershaw

Social media use by patients with hypermobile EDS

 There is an enormous capacity for how social media in our current age can be utilized. In cases of chronic diseases such as Ehlers-Danlos Syndrome (EDS),

Sam Vershaw

On the Increase in Use of GLP-1s

GLP-1 agonists, which include Ozempic, Mounjaro, and Wegovy, are already FDA-approved for type-2 diabetes, weight loss, and heart disease. Research shows a 40-fold increase in

Pierce Logan, MA
Nicolas Oliver, MA

The Value of the Holocaust in Medical Education

A brief summary and response to the 2024 Silvers' Annual Lecture by the same name.

Nicolas Oliver
Peter Schwartz, MD, PhD

Dangerous Ignorance: What Patients Don’t Understand about Pharmacogenomics

Peter Schwartz, MD, PhD., writes about the emerging importance of pharmacogenomics as well as current shortcomings in patients' understanding of pharmacogenomic testing results.

Peter Schwartz, MD, PhD
The Naloxbox at IUPUI, containing opioid rescue kits (Narcan).

NaloxBoxes

Read all about the effects and ethics of the new NaloxBox at IUPUI, a Narcan distribution machine that's saving lives!

Morgan Rich